Karin Abarca Heidemann, PhD

Vice President of Scientific Operations

Karin Abarca Heidemann, PhD, joined Champions Oncology in September of 2019 and currently serves as Vice President of Scientific Operations. Dr Abarca Heidemann oversees all aspects of Champions translational oncology services including in-vitro and ex-vivo programs encompassing pre-clinical, co-clinical and CLIA approved drug sensitivity testing. Prior to joining the Champions team, she served as VP of scientific operations at Rockland Immunochemicals Inc, leading product development & launch, and streamlining the production processes of top product lines for life sciences and bioprocessing markets. Dr. Abarca Heidemann was trained in Leadership & Strategic Management at the Wharton School of Business, holds a doctorate in biophysics from the University of Cologne, Germany, and served postdoctoral fellowships in structural biology and biochemistry at Johann Wolfgang Goethe University FFM, Germany, UTHSC San Antonio and Temple University.